Related Experiment Video
Updated: May 3, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Modeling of Menkes disease via human induced pluripotent stem cells
Ji-Hoon Suh1, Dongkyu Kim2, Hyemin Kim2
1Graduate Schools of Medical Science and Engineering, KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon 305-701, Republic of Korea.
Abstract:
Menkes disease (MD) is a copper-deficient neurodegenerative disorder that manifests severe neurologic symptoms such as seizures, lethargic states, and hypotonia. Menkes disease is due to a dysfunction of ATP7A, but the pathophysiology of neurologic manifestation is poorly understood during embryonic development. To understand the pathophysiology of neurologic symptoms, molecular and cellular phenotypes were investigated in Menkes disease-derived induced pluripotent stem cells (MD-iPSCs). MD-iPSCs were generated from fibroblasts of a Menkes disease patient. Abnormal reticular distribution of ATP7A was observed in MD-fibroblasts and MD-iPSCs, respectively. MD-iPSCs showed abnormal morphology in appearance during embryoid body (EB) formation as compared with wild type (WT)-iPSCs. Intriguingly, aberrant switch of E-cadherin (E-cad) to N-cadherin (N-cad) and impaired neural rosette formation were shown in MD-iPSCs during early differentiation. When extracellular copper was chelated in WT-iPSCs by treatment with bathocuprione sulfate, aberrant switch of E-cad to N-cad and impaired neuronal differentiation were observed, like in MD-iPSCs. Our results suggest that neurological defects in Menkes disease patients may be responsible for aberrant cadherin transition and impaired neuronal differentiation during early developmental stage.
Insights
Menkes disease (MD) involves copper deficiency and neurological issues. This study reveals that problems with ATP7A in MD-derived stem cells cause abnormal cell adhesion and impaired neural development, explaining neurological symptoms.
Area of Science:
- Neuroscience
- Developmental Biology
- Genetics
Background:
- Menkes disease (MD) is a severe neurodegenerative disorder caused by ATP7A dysfunction, leading to copper deficiency.
- The precise mechanisms underlying neurological symptoms during embryonic development remain unclear.
Purpose of the Study:
- To investigate the molecular and cellular phenotypes of Menkes disease-derived induced pluripotent stem cells (MD-iPSCs).
- To elucidate the pathophysiology of neurological manifestations in Menkes disease during early development.
Main Methods:
- Generated MD-iPSCs from patient fibroblasts.
- Analyzed ATP7A distribution, cell morphology during embryoid body formation, and cadherin switching (E-cadherin to N-cadherin).
- Compared MD-iPSCs with wild-type (WT)-iPSCs and copper-depleted WT-iPSCs.
Main Results:
- Observed abnormal ATP7A distribution in MD-fibroblasts and MD-iPSCs.
- MD-iPSCs exhibited abnormal morphology and impaired neural rosette formation during differentiation.
- Demonstrated an aberrant switch from E-cadherin to N-cadherin in MD-iPSCs, mimicking copper-chelated WT-iPSCs.
Conclusions:
- Neurological defects in Menkes disease may stem from aberrant cadherin transition during early development.
- Impaired neuronal differentiation due to copper deficiency is a key factor in MD's pathophysiology.
- MD-iPSCs serve as a valuable model for studying neurodevelopmental defects in Menkes disease.
More Related Videos
Related Concept Videos
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
iPS Cell Differentiation

